Skip header and navigation
Did you mean topic:"haemodialysis"? Also try haemodialysis.

Narrow By

18 records – page 1 of 1.

Acute hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams35036
Nova Scotia Health Authority. QEII. Nephrology Services. Halifax, NS: Nova Scotia Health Authority , 2017.
Pamphlet Number
1151
Available Online
View Pamphlet
Dialysis is a life-saving treatment which takes away waste and extra water from the blood. This pamphlet discusses why your kidneys are important and how you will feel if waste products build up in your blood. It defines acute kidney failure, dialysis, and hemodialysis. It discusses how long, and how often the treatment is needed and the special catheters needed for the treatment. Challenges for those living with kidney disease, resources available, as well as instructions for follow-up care ar…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Nephrology Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2017
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Acute Kidney Injury
Kidney Diseases - therapy
Subjects (LCSH)
Hemodialysis
Acute renal failure
Abstract
Dialysis is a life-saving treatment which takes away waste and extra water from the blood. This pamphlet discusses why your kidneys are important and how you will feel if waste products build up in your blood. It defines acute kidney failure, dialysis, and hemodialysis. It discusses how long, and how often the treatment is needed and the special catheters needed for the treatment. Challenges for those living with kidney disease, resources available, as well as instructions for follow-up care are given.
Responsibility
Prepared by: Nephrology Services
Pamphlet Number
1151
Less detail

Arteriovenous access surgery : ensuring adequate vascular access for hemodialysis

https://libcat.nshealth.ca/en/permalink/provcat33946
Hans Scholz ; in collaboration with U. Krüger, K. Petzold, and W. Munsch ; with extra chapters by J. Janzen and U. Krüger. (English edition) --Heidelberg: Springer , c2015.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Scholz, Hans
Other Authors
Krüger, U.
Petzold, K.
Munsch, W.
Janzen, J.
Responsibility
Hans Scholz ; in collaboration with U. Krüger, K. Petzold, and W. Munsch ; with extra chapters by J. Janzen and U. Krüger
Edition
English edition
Place of Publication
Heidelberg
Publisher
Springer
Date of Publication
c2015
Physical Description
1 online resource (xvii, 250 pages)
ISBN
9783642411397 (electronic bk.)
9783642411380
Subjects (MeSH)
Arteriovenous Shunt, Surgical
Renal Dialysis
Vascular Access Devices
Subjects (LCSH)
Blood-vessels - Surgery
Intravenous catheterization
Arterial catheterization
Hemodynamics
Hemodialysis
Notes
"Translated from the original German edition by M. Wunsch."
Contents
1. Introduction -- 2. Central Venous Catheters for Hemodialysis -- 3. AV Fistulas -- 4. AV Shunts -- 5. Arterioarterial Grafts -- 6. Redo Surgery with Prosthetic Grafts -- 7. Infections -- 8. Venous Congestion After the Creation of AV Accesses -- 9. Stenoses and Occlusions of the Central Veins -- 10. Leakage of ePTFE Grafts (Perigraft Seroma) -- 11. Insufficient Peripheral Perfusion and Cardiac Strain After AV Access Creation -- 12. Arterial Reconstructions of AV Accesses -- 13. Lymph Edema of the Arm After AV Access Surgery -- 14. Nerve Lesions After AV Access Surgery -- 15. Special Patient Groups -- 16. Anticoagulation with AV Accesses -- 17. Puncture Techniques -- 18. Monitoring of Vascular Accesses -- 19. Histopathology of AV Vascular Accesses -- 20. Short Introduction to Fluid Dynamics: Relevant Aspects for Hemodynamics -- 21. Our Methods -- Appendix -- Glossary.
Format
e-Book
Location
Online
Less detail

Care of your arteriovenous fistula

https://libcat.nshealth.ca/en/permalink/chpams35622
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
0651
Available Online
View Pamphlet
A fistula gives access to your bloodstream for hemodialysis. It is made by joining an artery and a vein during surgery. This pamphlet explains the surgery for having an arteriovenous fistula created in your forearm. Topics include: when is my fistula ready to use, after surgery, exercising, and how to care for your fistula. This pamphlet explains what to do if you have bleeding at the site, and a list of symptoms that need medical attention right away.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Central Venous Catheters
Renal Dialysis
Subjects (LCSH)
Hemodialysis
Specialty
Nephrology
Abstract
A fistula gives access to your bloodstream for hemodialysis. It is made by joining an artery and a vein during surgery. This pamphlet explains the surgery for having an arteriovenous fistula created in your forearm. Topics include: when is my fistula ready to use, after surgery, exercising, and how to care for your fistula. This pamphlet explains what to do if you have bleeding at the site, and a list of symptoms that need medical attention right away.
Responsibility
Prepared by: Renal Program
Pamphlet Number
0651
Less detail

Chronic kidney disease, dialysis, and transplantation : a companion to Brenner and Rector’s The Kidney

https://libcat.nshealth.ca/en/permalink/provcat31616
[edited by] Jonathan Himmelfarb, T. Alp Ikizler. (4th ed.) --Philadelphia, PA: Elsevier , c2019.
Available Online
View e-Book
Access
Registration required for PDF access.
Location
Online
From basic science to practical clinical tools, Chronic Kidney Disease, Dialysis, and Transplantation, 4th Edition provides you with the up-to-date, authoritative guidance you need to safely and effectively manage patients with chronic renal disease. Covering all relevant clinical management issues, this companion volume to Brenner and Rector’s The Kidney presents the knowledge and expertise of renowned researchers and clinicians in the fields of hemodialysis, peritoneal dialysis, critical car…
Available Online
View e-Book
Other Authors
Himmelfarb, Jonathan
Ikizler, T Alp
Responsibility
[edited by] Jonathan Himmelfarb, T. Alp Ikizler
Edition
4th ed.
Alternate Title
Chronic kidney disease, dialysis, & transplantation
Place of Publication
Philadelphia, PA
Publisher
Elsevier
Date of Publication
c2019
Physical Description
1 online resource, 780 p.
ISBN
9780323529785
Subjects (MeSH)
Renal Dialysis
Kidney Failure, Chronic - complications
Kidney Failure, Chronic - therapy
Kidney Transplantation
Subjects (LCSH)
Hemodialysis
Kidneys - Transplantation
Renal Dialysis
Kidney Failure, Chronic - complications
Kidney Failure, Chronic - therapy
Kidney Transplantation
Specialty
Nephrology
Abstract
From basic science to practical clinical tools, Chronic Kidney Disease, Dialysis, and Transplantation, 4th Edition provides you with the up-to-date, authoritative guidance you need to safely and effectively manage patients with chronic renal disease. Covering all relevant clinical management issues, this companion volume to Brenner and Rector’s The Kidney presents the knowledge and expertise of renowned researchers and clinicians in the fields of hemodialysis, peritoneal dialysis, critical care nephrology, and transplantation - for an all-in-one, indispensable guide to every aspect of this fast-changing field.
Access
Registration required for PDF access.
Format
e-Book
Location
Online
Less detail

Dalteparin (Fragmin) to prevent clotting during hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams35807
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
1760
Available Online
View Pamphlet
Dalteparin is a medication that is part of a group of drugs called blood thinners. Fragmin® is the brand name of dalteparin. During hemodialysis your blood passes through the dialysis blood lines and a dialyzer (artificial kidney), which can cause clots to form. Dalteparin stops clots from forming. This pamphlet explains how to take dalteparin, possible side effects, and symptoms that you should mention to your nurse.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Dalteparin
Renal Dialysis
Subjects (LCSH)
Hemodialysis
Blood--coagulation
Specialty
Nephrology
Abstract
Dalteparin is a medication that is part of a group of drugs called blood thinners. Fragmin® is the brand name of dalteparin. During hemodialysis your blood passes through the dialysis blood lines and a dialyzer (artificial kidney), which can cause clots to form. Dalteparin stops clots from forming. This pamphlet explains how to take dalteparin, possible side effects, and symptoms that you should mention to your nurse.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1760
Less detail

Dialysis patients on Warfarin who need interventional radiology procedures

https://libcat.nshealth.ca/en/permalink/chpams35344
Nova Scotia Health Authority. QEII. Pharmacy Department, Nova Scotia Health Authority. QEII. Vascular Services. Halifax, NS: Nova Scotia Health Authority , 2016.
Pamphlet Number
1444
Available Online
View Pamphlet
This pamphlet gives specific directions if you are a dialysis patient on Warfarin and you are undergoing interventional radiology procedures. Space is provided to write the name and date of your procedure as well as what medicine(s) to stop taking before your procedure. Directions about when to have blood work done as well as when to restart your medicine(s) after the procedure are provided.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Pharmacy Department
Nova Scotia Health Authority. QEII. Vascular Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2016
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Nephrology
Warfarin
Renal Dialysis
Radiology, Interventional
Subjects (LCSH)
Nephrology
Hemodialysis
Warfarin
Interventional radiology
Abstract
This pamphlet gives specific directions if you are a dialysis patient on Warfarin and you are undergoing interventional radiology procedures. Space is provided to write the name and date of your procedure as well as what medicine(s) to stop taking before your procedure. Directions about when to have blood work done as well as when to restart your medicine(s) after the procedure are provided.
Notes
Previous title: Hemodialysis instead of dialysis
Responsibility
Prepared by: Dr. Jo-Anne Wilson, Clinical Pharmacy Coordinator ; Paula Mossop, Vascular Access Nurse
Pamphlet Number
1444
Less detail

Fer injectable et insuffisance rénale chronique (IRC)

https://libcat.nshealth.ca/en/permalink/chpams37473
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
2161
Available Online
View Pamphlet
Si votre corps manque d’oxygène en raison d’une carence en fer, il se peut que vous soyez fatigué ou essoufflé. On appelle cela l’anémie ferriprive. Beaucoup de patients atteints d’insuffisance rénale chronique (IRC) ou dialysés souffrent d’anémie, car ils n’ont pas assez de globules rouges, et le corps a besoin de fer pour les fabriquer. Prendre du fer par injection permet donc au corps d’avoir suffisamment de fer pour fabriquer de l’hémoglobine, c’est-à-dire la protéine qui transporte l’oxygè…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Alternate Title
Injectable iron and chronic kidney disease (CKD)
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Iron - therapeutic use
Kidney Diseases
Anemia, Iron-Deficiency
Subjects (LCSH)
Hemodialysis
Chronic renal failure--Complications
Iron deficiency anemia
Abstract
Si votre corps manque d’oxygène en raison d’une carence en fer, il se peut que vous soyez fatigué ou essoufflé. On appelle cela l’anémie ferriprive. Beaucoup de patients atteints d’insuffisance rénale chronique (IRC) ou dialysés souffrent d’anémie, car ils n’ont pas assez de globules rouges, et le corps a besoin de fer pour les fabriquer. Prendre du fer par injection permet donc au corps d’avoir suffisamment de fer pour fabriquer de l’hémoglobine, c’est-à-dire la protéine qui transporte l’oxygène. Ce dépliant explique comment prendre du fer injectable, ses effets possibles et comment le conserver.
This pamphlet is a French translation of the English pamphlet 1495, "Injectable Iron and Chronic Kidney Disease (CKD)". If your body is not getting enough oxygen due to lack of iron, you may feel tired or short of breath. This is called iron deficiency anemia. Many patients with chronic kidney disease (CKD), or who are on dialysis, have anemia because their red blood cells are low. The body needs iron to help make new red blood cells. Getting iron injections can help make sure that you have enough iron in your body to make the oxygen-carrying part (hemoglobin) of your red blood cells. This pamphlet explains how to take injectable iron, side effects to watch for, and instructions on how to store the medication.
Notes
Previous title: Injectable iron sucrose and chronic kidney disease
Responsibility
Prepared by: NSHA Renal Program
Pamphlet Number
2161
Less detail

Heparin to prevent clotting during hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams35407
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2017.
Pamphlet Number
1494
Available Online
View Pamphlet
This pamphlet explains how heparin can help a person with kidney disease who is on hemodialysis. This medicine helps people with kidney disease by preventing blood from clotting in the dialysis lines during hemodialysis. How to take the medicine and what side effects to watch for are reviewed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2017
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Heparin - therapeutic use
Anticoagulants - therapeutic use
Subjects (LCSH)
Heparin
Anticoagulants (Medicine)
Hemodialysis
Specialty
Nephrology
Medications
Abstract
This pamphlet explains how heparin can help a person with kidney disease who is on hemodialysis. This medicine helps people with kidney disease by preventing blood from clotting in the dialysis lines during hemodialysis. How to take the medicine and what side effects to watch for are reviewed.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1494
Less detail

Home therapy options for dialysis

https://libcat.nshealth.ca/en/permalink/chpams35224
Nova Scotia Health Authority. Home Dialysis Unit. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1341
Available Online
View Pamphlet
Staff in the Home Dialysis Unit at the Queen Elizabeth II Health Sciences Centre (QEII) teach patients how to do dialysis treatments at home. This pamphlet gives information about where to stay if you live more than 40 km (25 miles) from Halifax, the dialysis training process, supplies, and follow-up. Different types of dialysis are explained.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Home Dialysis Unit
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (10 p.) : digital, PDF file
Subjects (MeSH)
Hemodialysis, Home
Subjects (LCSH)
Home hemodialysis
Specialty
Nephrology
Abstract
Staff in the Home Dialysis Unit at the Queen Elizabeth II Health Sciences Centre (QEII) teach patients how to do dialysis treatments at home. This pamphlet gives information about where to stay if you live more than 40 km (25 miles) from Halifax, the dialysis training process, supplies, and follow-up. Different types of dialysis are explained.
Responsibility
Prepared by: Home Dialysis Unit
Pamphlet Number
1341
Less detail

Injectable iron and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35408
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
1495
Available Online
View Pamphlet
If your body is not getting enough oxygen due to lack of iron, you may feel tired or short of breath. This is called iron deficiency anemia. Many patients with chronic kidney disease (CKD), or who are on dialysis, have anemia because their red blood cells are low. The body needs iron to help make new red blood cells. Getting iron injections can help make sure that you have enough iron in your body to make the oxygen-carrying part (hemoglobin) of your red blood cells. This pamphlet explains how …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Iron - therapeutic use
Kidney Diseases
Anemia, Iron-Deficiency
Subjects (LCSH)
Hemodialysis
Chronic renal failure--Complications
Iron deficiency anemia
Abstract
If your body is not getting enough oxygen due to lack of iron, you may feel tired or short of breath. This is called iron deficiency anemia. Many patients with chronic kidney disease (CKD), or who are on dialysis, have anemia because their red blood cells are low. The body needs iron to help make new red blood cells. Getting iron injections can help make sure that you have enough iron in your body to make the oxygen-carrying part (hemoglobin) of your red blood cells. This pamphlet explains how to take injectable iron, side effects to watch for, and instructions on how to store the medication. The French version of this pamphlet 2161, "Fer injectable et insuffisance rénale chronique (IRC)," is also available.
Notes
Previous title: Injectable iron sucrose and chronic kidney disease
Responsibility
Prepared by: NSHA Renal Program
Pamphlet Number
1495
Less detail

Lanthanum (Fosrenol) and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35370
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
1466
Available Online
View Pamphlet
Lanthanum (LAN-tha-num) is a medicine used to treat high levels of phosphorus (a mineral that builds strong bones and teeth) in the body. Lanthanum binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. People with kidney disease are less able to remove phosphorus from the body. When phosphorus levels in the blood get too high, it pushes calcium out from your bones. This makes them weaker. Hemodialysis can remove some of the extra phosphorus, but medicin…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Insufficiency, Chronic - drug therapy
Renal Dialysis
Lanthanum
Subjects (LCSH)
Chronic renal failure
Kidneys--Diseases--Treatment
Hemodialysis
Abstract
Lanthanum (LAN-tha-num) is a medicine used to treat high levels of phosphorus (a mineral that builds strong bones and teeth) in the body. Lanthanum binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. People with kidney disease are less able to remove phosphorus from the body. When phosphorus levels in the blood get too high, it pushes calcium out from your bones. This makes them weaker. Hemodialysis can remove some of the extra phosphorus, but medicines such as lanthanam are often needed to help remove more. How to take the medicine and what side effects to watch for are reviewed. Fosrenol® is a brand name for lanthanum.
Notes
Previous title: Fosrenol (Lanthanum) and hemodialysis
Responsibility
Prepared by: NSHA Renal Program
Pamphlet Number
1466
Less detail

Nocturnal dialysis diet

https://libcat.nshealth.ca/en/permalink/chpams35668
Nova Scotia Health Authority. Central Zone. Food and Nutrition Services. Halifax, NS: Nova Scotia Health Authority , 2016.
Pamphlet Number
1655
Available Online
View Pamphlet
Nocturnal Home Hemodialysis (NHHD) is a type of dialysis done at home overnight, usually for 8-9 hours, 5-6 nights per week. Topics include: protein, sample meal plan, phosphorus, sodium, fluids, and potassium.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Central Zone. Food and Nutrition Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2016
Format
Pamphlet
Language
English
Physical Description
1 electronic document (12 p.) : digital, PDF file
Subjects (MeSH)
Kidney Diseases - diet therapy
Hemodialysis, Home
Subjects (LCSH)
Kidneys--Diseases--Nutritional aspects
Home hemodialysis
Specialty
Food and Nutrition
Abstract
Nocturnal Home Hemodialysis (NHHD) is a type of dialysis done at home overnight, usually for 8-9 hours, 5-6 nights per week. Topics include: protein, sample meal plan, phosphorus, sodium, fluids, and potassium.
Responsibility
Prepared by: Food & Nutrition Services
Pamphlet Number
1655
Less detail

Non-tunneled hemodialysis catheter

https://libcat.nshealth.ca/en/permalink/chpams35618
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1093
Available Online
View Pamphlet
A non-tunneled hemodialysis catheter is a special tube made of plastic. It is used for hemodialyis treatment. This pamphlet explains the procedure for having a non-tunneled hemodialysis cathether inserted. Topics include: why the catheter is used, how long it can stay in place, how it is inserted, what will happen after the procedure, and how to care for your catheter at home. The pamphlet also explains what to do if the catheter falls out.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Vascular Access Devices
Subjects (LCSH)
Catheters
Hemodialysis
Specialty
Nephrology
Abstract
A non-tunneled hemodialysis catheter is a special tube made of plastic. It is used for hemodialyis treatment. This pamphlet explains the procedure for having a non-tunneled hemodialysis cathether inserted. Topics include: why the catheter is used, how long it can stay in place, how it is inserted, what will happen after the procedure, and how to care for your catheter at home. The pamphlet also explains what to do if the catheter falls out.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1093
Less detail

One-Alpha® (alfacalcidol) and hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams36672
Nova Scotia Health Authority. Pharmacy Services, Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
1470
Available Online
View Pamphlet
One-Alpha® is a medicine that contains the active ingredient alfacalcidol, which is a form of vitamin D. The liver changes alfacalcidol to calcitriol, which is a form of vitamin D that can be used by the body. It acts as a hormone in your body to control the levels of calcium and phosphate, which are needed to build healthy bone. People with kidney disease cannot change enough vitamin D into calcitriol. We get vitamin D from sunlight, and from eating oily fish and milk products. This can cause …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Insufficiency, Chronic - drug therapy
Renal Dialysis
Subjects (LCSH)
Chronic renal failure
Kidneys--Diseases--Treatment
Hemodialysis
Abstract
One-Alpha® is a medicine that contains the active ingredient alfacalcidol, which is a form of vitamin D. The liver changes alfacalcidol to calcitriol, which is a form of vitamin D that can be used by the body. It acts as a hormone in your body to control the levels of calcium and phosphate, which are needed to build healthy bone. People with kidney disease cannot change enough vitamin D into calcitriol. We get vitamin D from sunlight, and from eating oily fish and milk products. This can cause low levels of calcium in the blood and bone problems. This medicine skips the step done by the kidneys and increases the amount of vitamin D in your body that can be used. How to take the medicine and what side effects to watch for are reviewed. One-Alpha® is a brand name for alfacalcidol.
Responsibility
Prepared by: Renal Pharmacy Team, NSHA Renal Program
Pamphlet Number
1470
Less detail

Renal (dialysis) patient handbook

https://libcat.nshealth.ca/en/permalink/chpams35162
Nova Scotia Health Authority. QEII. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2017.
Pamphlet Number
1220
Available Online
View Pamphlet
This pamphlet provides information about the renal (kidney dialysis) program. It outlines home therapies (having dialysis in your own home), as well as what to expect on your first day of dialysis and your routines. An outline of your dialysis team members, travel while on dialysis, and helpful resources are provided. A list of important contact information is given.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Renal Program
Alternate Title
Dialysis patient handbook
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2017
Format
Pamphlet
Language
English
Physical Description
1 electronic document (19 p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Kidney Diseases - therapy
Subjects (LCSH)
Hemodialysis
Kidneys--Diseases
Abstract
This pamphlet provides information about the renal (kidney dialysis) program. It outlines home therapies (having dialysis in your own home), as well as what to expect on your first day of dialysis and your routines. An outline of your dialysis team members, travel while on dialysis, and helpful resources are provided. A list of important contact information is given.
Notes
Previous title: Hemodialysis patient handbook
Responsibility
Prepared by: Renal Program, Central Zone, Halifax NS, Canada
Pamphlet Number
1220
Less detail

Rocaltrol® (calcitriol) and hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams36671
Nova Scotia Health Authority. Pharmacy Services, Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
1468
Available Online
View Pamphlet
Rocaltrol® is a medicine that contains the active ingredient calcitriol, which is a form of vitamin D that can be used by the body. It acts as a hormone in your body to control the levels of calcium and phosphate, which are needed to build healthy bone. People with kidney disease cannot change enough vitamin D into calcitriol. We get vitamin D from sunlight, and from eating oily fish and milk products. This can cause low levels of calcium in the blood and bone problems. This medicine skips the …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Insufficiency, Chronic - drug therapy
Renal Dialysis
Calcitriol
Subjects (LCSH)
Chronic renal failure
Kidneys--Diseases--Treatment
Hemodialysis
Abstract
Rocaltrol® is a medicine that contains the active ingredient calcitriol, which is a form of vitamin D that can be used by the body. It acts as a hormone in your body to control the levels of calcium and phosphate, which are needed to build healthy bone. People with kidney disease cannot change enough vitamin D into calcitriol. We get vitamin D from sunlight, and from eating oily fish and milk products. This can cause low levels of calcium in the blood and bone problems. This medicine skips the step done by the kidneys and increases the amount of vitamin D in your body that can be used. How to take the medicine and what side effects to watch for are reviewed. Rocaltrol® is a brand name for calcitriol.
Responsibility
Prepared by: Renal Pharmacy Team, NSHA Renal Program
Pamphlet Number
1468
Less detail

Sevelamer (Renagel) and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35372
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
1464
Available Online
View Pamphlet
Sevelamer (se-VEL-a-mer) is a medicine used to treat high levels of phosphorus (a mineral that builds strong bones and teeth) in the body. People with kidney disease are less able to remove phosphorus from their body. When phosphorus levels in the blood get too high, it pushes calcium out from your bones. Hemodialysis can remove some of the extra phosphorus, but medicines such as sevelamer are often needed to help remove more. How to take sevelamer and what side effects to watch for are reviewe…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Sevelamer
Renal Insufficiency, Chronic - drug therapy
Renal Dialysis
Subjects (LCSH)
Hemodialysis
Chronic renal failure
Kidneys--Diseases--Treatment
Abstract
Sevelamer (se-VEL-a-mer) is a medicine used to treat high levels of phosphorus (a mineral that builds strong bones and teeth) in the body. People with kidney disease are less able to remove phosphorus from their body. When phosphorus levels in the blood get too high, it pushes calcium out from your bones. Hemodialysis can remove some of the extra phosphorus, but medicines such as sevelamer are often needed to help remove more. How to take sevelamer and what side effects to watch for are reviewed. Renagel® is a brand name for sevelamer.
Notes
Previous title: Renagel (Sevelamer) and Hemodialysis
Responsibility
Prepared by: NSHA Renal Program
Pamphlet Number
1464
Less detail

Tunneled hemodialysis catheter

https://libcat.nshealth.ca/en/permalink/chpams35616
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1032
Available Online
View Pamphlet
A tunneled hemodialysis catheter is a special tube made of plastic. It is used for hemodialysis treatment. This pamphlet explains the procedure for having a tunneled hemodialysis catheter inserted. Topics include: why the catheter is used, how long it will be in place, where the procedure is done, how long you will be at the hospital, how to get ready, and how the catheter is inserted. Instructions for after your procedure and care at home are provided.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Vascular Access Devices
Subjects (LCSH)
Hemodialysis
Catheters
Specialty
Nephrology
Abstract
A tunneled hemodialysis catheter is a special tube made of plastic. It is used for hemodialysis treatment. This pamphlet explains the procedure for having a tunneled hemodialysis catheter inserted. Topics include: why the catheter is used, how long it will be in place, where the procedure is done, how long you will be at the hospital, how to get ready, and how the catheter is inserted. Instructions for after your procedure and care at home are provided.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1032
Less detail

18 records – page 1 of 1.